Brian McNamee
Vorsitzender bei CSL LIMITED
Vermögen: 23 Mio $ am 30.04.2024
Aktive Positionen von Brian McNamee
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ZENYTH THERAPEUTICS LIMITED | Direktor/Vorstandsmitglied | - | - |
CSL LIMITED | Independent Dir/Board Member | 14.02.2018 | - |
Vorsitzender | 17.10.2018 | - | |
Direktor/Vorstandsmitglied | 14.02.2018 | 17.10.2018 | |
Geoff Ogilvy Foundation | Vorsitzender | 01.05.2021 | - |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Vorsitzender | - | - |
Karriereverlauf von Brian McNamee
Ehemalige bekannte Positionen von Brian McNamee
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Genesis Care Pty Ltd.
Genesis Care Pty Ltd. Hospital/Nursing ManagementHealth Services Genesis Care Pty Ltd. engages in the provision of radiation oncology cardiology and sleep treatments. It offers oncology, cardiology, sleep medicine, and theranostics. The company was founded by Dan Collins in 2009 and is headquartered in Alexandria, Australia. | Vorsitzender | 01.07.2019 | 01.06.2022 |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Präsident | - | 01.07.2013 |
CSL LIMITED | Direktor/Vorstandsmitglied | 02.02.2011 | 01.07.2013 |
Präsident | 26.06.2009 | 01.07.2013 | |
Gen-Probe, Inc.
Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | 01.09.2002 | 31.05.2007 |
Tarnagulla Ventures Pty Ltd.
Tarnagulla Ventures Pty Ltd. Investment ManagersFinance Tarnagulla Ventures Pty Ltd (Tarnagulla Ventures) is a venture capital firm founded in 2015. The firm is headquartered in Melbourne, Australia. | Private Equity Investor | - | - |
░░░░░ ░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░ ░░░░░░░░ ░ ░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Brian McNamee
University of Melbourne | Doctorate Degree |
Statistik
International
Australien | 10 |
Vereinigte Staaten | 3 |
Operativ
Director/Board Member | 6 |
Chairman | 4 |
President | 3 |
Sektoral
Health Technology | 6 |
Consumer Services | 2 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CSL LIMITED | Health Technology |
Private Unternehmen | 9 |
---|---|
Gen-Probe, Inc.
Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Health Technology |
CSL Innovation Pty Ltd.
CSL Innovation Pty Ltd. Pharmaceuticals: MajorHealth Technology CSL Innovation Pty Ltd. develops pharmaceutical products. The firm also develops human antibody inhibitors of the granulocyte-macrophage colony stimulating factor receptor alpha subunit, GM-CSFRa, for potential therapeutic use in inflammatory diseases. The company was founded in 1986 and is headquartered in Richmond, Australia. | Health Technology |
Pacific Biotechnology Ltd. | |
FH Faulding & Co. Ltd. | Health Technology |
Peter Maccallum Cancer Foundation Ltd. | |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Health Technology |
Tarnagulla Ventures Pty Ltd.
Tarnagulla Ventures Pty Ltd. Investment ManagersFinance Tarnagulla Ventures Pty Ltd (Tarnagulla Ventures) is a venture capital firm founded in 2015. The firm is headquartered in Melbourne, Australia. | Finance |
Genesis Care Pty Ltd.
Genesis Care Pty Ltd. Hospital/Nursing ManagementHealth Services Genesis Care Pty Ltd. engages in the provision of radiation oncology cardiology and sleep treatments. It offers oncology, cardiology, sleep medicine, and theranostics. The company was founded by Dan Collins in 2009 and is headquartered in Alexandria, Australia. | Health Services |
Geoff Ogilvy Foundation |
- Börse
- Insiders
- Brian McNamee
- Erfahrung